2002
DOI: 10.1016/s0959-4388(02)90328-4
|View full text |Cite
|
Sign up to set email alerts
|

Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…The post-genomic era The availability of genomic sequence data for numerous Gram-positive bacteria, including three pneumococcal strains, has facilitated the identification of additional pneumococcal surface molecules (e.g., [15,27,28]). These analyses have led to the identification of many new surface molecules compared to the pregenomic era, and have often relied on searches for specific signatures in sequences of open reading frames (ORF) coding for such proteins.…”
Section: Introductionmentioning
confidence: 99%
“…The post-genomic era The availability of genomic sequence data for numerous Gram-positive bacteria, including three pneumococcal strains, has facilitated the identification of additional pneumococcal surface molecules (e.g., [15,27,28]). These analyses have led to the identification of many new surface molecules compared to the pregenomic era, and have often relied on searches for specific signatures in sequences of open reading frames (ORF) coding for such proteins.…”
Section: Introductionmentioning
confidence: 99%
“…The high morbidity and mortality associated with pneumococcal diseases are exacerbated by the rate at which this organism is acquiring resistance to multiple antibiotics and the limitation in the clinical efficacy of current vaccines, especially for high-risk groups, such as young children and the elderly (5,20). A more detailed understanding of S. pneumoniae virulence is likely to provide new vaccine candidates and targets for antibacterial drugs (12,16,38).…”
mentioning
confidence: 99%
“…S. pneumoniae is a major pathogen suitable as a model system for biomedical studies [28]. In order to select cHPs of S. pneumoniae R6 that were truly uncharacterised and that were chemically amenable to experimental analysis, 858 potential cHPs were initially selected (Figure 1).…”
Section: Resultsmentioning
confidence: 99%